Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

CorMedix (CRMD) Goodwill & Intangibles (2019 - 2025)

CorMedix (CRMD) has disclosed Goodwill & Intangibles for 4 consecutive years, with $423.1 million as the latest value for Q4 2025.

Quarterly Goodwill & Intangibles rose 21055.1% to $423.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $423.1 million through Dec 2025, up 21055.1% year-over-year, with the annual reading at $423.1 million for FY2025, 21055.1% up from the prior year.
Goodwill & Intangibles hit $423.1 million in Q4 2025 for CorMedix, up from $411.4 million in the prior quarter.
In the past five years, Goodwill & Intangibles ranged from a high of $423.1 million in Q4 2025 to a low of $1.7 million in Q2 2025.